School of Medicine


Showing 601-610 of 939 Results

  • Curtis R. Chong, MD, PhD, MPhil, FACP

    Curtis R. Chong, MD, PhD, MPhil, FACP

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Chong was recruited to Stanford from the Memorial Sloan Kettering (MSK) Cancer Center, where he led MSK's launch of the early drug development and immunotherapy clinical trials program in New Jersey. At MSK, Dr. Chong was a member of the gastrointestinal oncology service and was one of two MSK physicians in New Jersey who specialized in treating melanoma. Prior to joining MSK, Dr. Chong was a member of the thoracic oncology service at the Dana-Farber Cancer Institute and an attending physician at the Massachusetts General Hospital and Brigham and Women's Hospital, all ailiates of Harvard Medical School.

    Dr. Chong completed his categorical residency in internal medicine at the Massachusetts General Hospital/Harvard Medical School, his oncology fellowship at the Dana-Farber Cancer Institute, and is board-certified in internal medicine and medical oncology. He has received research support from the American Society of Clinical Oncology (Young Investigator Award), Uniting Against Lung Cancer, and the American Cancer Society. Dr. Chong has been published in the New England Journal of Medicine, Nature, Nature Medicine, Nature Chemical Biology, JAMA Oncology, and his research on drug discovery has been featured in the New York Times and Popular Science.

    Born and raised in Honolulu where he attended public schools, Dr. Chong sang in the Honolulu Boy Choir, and was the 1993 Honolulu Star Bulletin Newspaper Boy of the Year. He received his A.B. in biochemical sciences from Harvard University magna cum laude followed by an M.Phil. in Chemistry with Sir Alan Fersht at the University of Cambridge (Emmanuel College). He then received his MD and PhD in pharmacology from The Johns Hopkins University School of Medicine.

    An intrepid traveler and avid long-distance runner, Dr. Chong has visited 54 countries and completed 126 marathons in all 50 states, 18 countries, and 6 on continents.

  • HyeRan Choo

    HyeRan Choo

    Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. HyeRan Choo is a Clinical Associate Professor of Plastic and Reconstructive Surgery in the Department of Surgery at Stanford University School of Medicine. She is Director of Neonatal and Pediatric Craniofacial Airway Orthodontics and Dental Sleep Medicine at Lucile Packard Children’s Hospital Stanford. She also directs the Neonatal and Pediatric Craniofacial Airway Orthodontic Fellowship in the Department of Surgery / Division of Plastic and Reconstructive Surgery. She is a Faculty Fellow of the Stanford Byers Center for Biodesign.

    After graduating from Seoul National University with a combined degree in Natural Sciences and Dental Surgery in 2002, Dr. Choo received her Dental Medicine degree from the University of Pennsylvania. She completed her orthodontic residency and Masters in Science degree program at the University of Alabama in Birmingham. Following her Craniofacial Fellowship at the Clinical Center of the National Institutes of Health (NIH) / National Institute of Dental and Craniofacial Research (NIDCR), Dr. Choo was recruited as a full-time faculty member at the University of Pennsylvania and The Children’s Hospital of Philadelphia. Dr. Choo joined the faculty of Stanford University School of Medicine in 2016. Dr. Choo is a board-certified craniofacial orthodontist by American Board of Orthodontics since 2008 and became a diplomate of the American Board of Dental Sleep Medicine in 2021.

    Dr. Choo’s areas of expertise are non-surgical airway management and facial reconstruction for newborns with cleft and/or Robin Sequence in the Neonatal Intensive Care Unit. Her treatments utilize simple custom-fabricated orthodontic devices to establish a healthy environment to correct neonatal orofacial abnormalities with great respect for natural growth potential of each neonate. She also practices the full scope of pediatric obstructive sleep apnea management as well as orthodontics and dentofacial orthopedics for patients with cleft and craniofacial abnormalities in a multi-disciplinary clinical setting.

    Dr. Choo’s treatment philosophy is based on a fundamental understanding of facial growth and oral functions (Biocreative Orthodontic Strategy). Her research focuses on translation of health innovation technology for the advancement of infant orthodontics. She also pioneers the development of skeletal anchorage-based orthodontic and orthopedic treatment strategies for pediatric sleep apnea patients.

  • Mehak Chopra

    Mehak Chopra

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioHer expertise lies in treating special populations such as athletes and students. She has also had training in dealing with cultural psychiatry issues. She has been trained to treat students with a variety of mental health issues – ADHD, Bipolar disorder, schizophrenia, eating disorders, insomnia, mood disorder and personality disorders.

  • Danny Hung-Chieh Chou

    Danny Hung-Chieh Chou

    Assistant Professor of Pediatrics (Endocrinology) and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsOur research program integrates concepts of chemical biology, protein engineering and structure biology to design new therapeutic leads and generate probes to study biological processes. A key focus of our lab is insulin, an essential hormone in our body to reduce blood glucose levels. We generate synthetic libraries of insulin analogs to select for chemical probes, and investigate natural insulin molecules (e.g. from the venom of fish-hunting cone snails!) to develop novel therapeutic candidates. We are especially interested in using chemical and enzymatic synthesis to create novel chemical entities with enhanced properties, and leverage the strong expertise of our collaborators to apply our skill sets in the fields of cancer biology, immunology and pain research. Our ultimate goal is to translate our discovery into therapeutic interventions in human diseases.